Author: Abigail Adcox, Washington Examiner
-

Mass vaccination of chickens against bird flu could hurt US sellers
A mass vaccination campaign for poultry against avian influenza that’s reportedly being considered by the Biden administration could hurt chicken farmers by making it harder for them to export birds. Several vaccines against different strains of bird flu have been developed and administered to poultry in other countries, including China, but the United States has…
-

New York state officials press pharmacies to dispense abortion pills
Gov. Kathy Hochul (D-NY) and state Attorney General Letitia James are pressuring pharmaceutical chains to commit to dispensing a major abortion drug in the state. The state officials have asked Walgreens, Rite Aid, and CVS Health to pledge to dispense mifepristone, the first of two abortion-inducing drugs used to terminate a pregnancy through 10 weeks,…
-

Texas sued over abortion laws by five women
Five women have filed a lawsuit against Texas, claiming that the state’s laws prevented them from getting abortions despite life-threatening circumstances in their pregnancies, in what is being deemed the first lawsuit brought by women denied abortions since the Supreme Court overturned Roe v. Wade. The women argue that they were denied abortions despite the…
-

North Carolina legislature strikes deal to expand Medicaid under Obamacare
North Carolina legislative leaders announced they have struck a deal to expand access to Medicaid for hundreds of thousands of additional low-income state residents through Obamacare, an agreement that comes after years of debate. House Speaker Tim Moore and Senate leader Phil Berger, both Republicans, said they have reached a compromise that is expected to…
-

Walgreens says it does not plan to sell abortion pills in some states its legal
Walgreens announced it does not plan to dispense a major abortion medication in some states where the pills remain legal amid a shifting landscape after a number of state officials threatened legal action. The company said that it does not plan to seek certification from the Food and Drug Administration to dispense mifepristone, the first…
-

Tennessee bans transgender procedures for minors two days after Mississippi
Tennessee Gov. Bill Lee signed legislation Thursday that will ban minors from accessing gender transition surgeries and hormone therapy two days after Mississippi’s governor signed a similar bill into law. The legislation will prohibit medical officials from prescribing puberty blockers to or performing gender transition procedures on people under 18. The Republican-controlled House passed the…
-

FDA vaccine advisers recommend approving RSV vaccines for older adults
The Food and Drug Administration’s vaccine advisory committee has recommended GlaxoSmithKline’s and Pfizer’s respiratory syncytial virus vaccine candidates for older adults, paving the way for approval of the country’s first RSV vaccine. The Vaccines and Related Biological Products Advisory Committee, the same group that reviews COVID-19 vaccines, voted unanimously on Wednesday that vaccine efficiency data…
-

Experts seek to allay fears of human-to-human transmission after bird flu death
Health officials said evidence suggests that two people diagnosed with bird flu, one of them fatal, in Cambodia were not infected through human-to-human transmission, allaying fears that the avian influenza is being spread between humans. An 11-year-old girl, who died earlier this month, and her father both tested positive for the H5N1 virus and are…
-

Hong Kong ends one of the world’s longest mask mandates after 959 days
Hong Kong lifted one of the world’s longest-standing mask mandates on Wednesday after 959 days as the city tries to rebuild its reputation as an international financial hub and renew tourism. Residents and tourists will no longer be required to wear face masks in indoor and outdoor areas in Hong Kong for the first time…
-

Drugmaker Eli Lilly caps price of insulin at $35 per month
Drugmaker Eli Lilly said Wednesday it would lower the prices of its most frequently used insulins by 70% and expand a program to cap out-of-pocket costs for patients at $35. The company will immediately cap out-of-pocket costs of insulin at $35 a month at participating retail pharmacies for people with private insurance, and those without…




